Solvay Pharmaceuticals, Inc. and Unimed Pharmaceuticals, Inc. Join National Program to Help Millions of Uninsured Americans
-- Partnership for Prescription Assistance Unites America’s Pharmaceutical Companies, Doctors and Other Health Care Providers, Patient Advocates and Community Groups --
Marietta, Ga. (April 11, 2005) – Solvay Pharmaceuticals, Inc. and its wholly owned subsidiary Unimed Pharmaceuticals, Inc., today announced their participation in the Partnership for Prescription Assistance, the largest-ever private-sector program to help patients who lack prescription coverage, joining a national coalition of pharmaceutical companies, doctors, nurses, other health care providers, pharmacists, patient advocates and community leaders.
"Solvay Pharmaceuticals’ participation in the Partnership for Prescription Assistance reinforces our long-standing commitment to helping people live better quality lives patients by assisting them in gaining access to the medicines they need through programs such as our own Patient Assistance Program," said Harold H. Shlevin, PhD, President and CEO of Solvay Pharmaceuticals, Inc. "We are pleased to join together with other pharmaceutical companies, health care providers and patient advocacy groups to help provide patients unprecedented access to our medications.”
The Partnership for Prescription Assistance offers a single point of access to more than 275 public and private patient assistance programs, including more than 150 programs offered by pharmaceutical companies. The Solvay Pharmaceuticals/Unimed Pharmaceuticals Patient Assistance Program will now be available through the Partnership for Prescription Assistance.
"In 2004 alone, Solvay Pharmaceuticals and its subsidiary, Unimed Pharmaceuticals, provided approximately 10,000 patients with free drugs valued at nearly $10 million through our company’s own Patient Assistance Program,” said Shlevin. “We look forward to working with the Partnership for Prescription Assistance to further expand patient access to our important medications.”
To find out if they qualify for one or more programs, patients can visit www.pparx.org or call toll–free 1-800-4PPA-NOW (1-888-477-2669) to speak with a trained specialist who can provide application assistance in English, Spanish and approximately 150 other languages.
Solvay Pharmaceuticals, Inc. (www.solvaypharmaceuticals-us.com) of Marietta, Georgia (USA) is a research-driven pharmaceutical company that seeks to fulfill unmet medical needs in the therapeutic areas of cardiology, gastroenterology, mental health, women's health and a select group of specialized markets including men's health. It is a part of the global Solvay Pharmaceuticals organization whose core activities consist of discovering, developing and manufacturing medicines for human use. Solvay Pharmaceuticals, Inc. is a subsidiary corporation of the worldwide Solvay Group of chemical and pharmaceutical companies headquartered in Brussels, Belgium.
